RNA Therapeutics Conference 2025

We are proud to announce the 15th Annual RNA Therapeutics Conference, taking place on the 10-11 February 2025 in London, UK.

The RNA therapeutics industry has grown exponentially in recent years, largely attributed to the advancements in CRISPR RNA-editing technologies, and increased exposure of RNA vaccines following the COVID-19 pandemic. This upward trajectory is expected to continue, with 131 candidate therapies in clinical trials as of January 2024.

Don’t get left behind! Join us to discuss the latest advancements in RNA therapeutics with leaders from across the life science sector.
 
Expect presentations and discussions addressing novel delivery methods and extra-hepatic delivery solutions, applications of AI for RNA sequence optimization and case studies of novel modalities progressing through the pipeline including circRNA, siRNA, miRNA, lncRNA and more. Further challenges that will be addressed include the lack of effective assays for in vivo analytical testing, including toxicity and immune-modulation considerations. We will also examine the rapidly changing regulatory landscape, identifying how the industry can adapt to meet changing guidelines and regulations.

Don't miss this opportunity to network with the pharma and biotech community of global experts in the UK and Europe; and help shape RNA therapeutic advancements! Our two-day agenda offers you peer-to-peer networking with Directors of key big pharma and biotech’s in the field, CEOs, Senior Scientists, Chief Medical Officers, Senior Vice Presidents and many more.

Why you should attend:

• Engage in the latest challenges in drug delivery and review the new and emerging alternatives to LNPs, that are broadening opportunities within tissue targeting.
• Network with peers and industry experts to share ideas, discover novel solutions to some of the industry’s biggest challenges including biodistribution, controlling immunogenicity and increasing longevity of RNA therapeutic action.
• Learn about novel modalities emerging in the space and the manufacturing and analytical strategies advancing development and synthesis of these RNA modalities.
• Build your ecosystem within RNA therapeutics to uncover potential collaborators and keep pace with this rapidly-advancing field.

Who should attend:

Any company striving to deliver optimal RNA therapies to patients in need.
If you or your company are working on or looking to break into any of the following areas, this conference is a must!

• RNA therapeutic research and development
• mRNA vaccines R&D
• RNA therapeutic delivery methods
• Analytical method development for oligonucleotide candidate testing
• RNA manufacturing
• RNA synthesis
• Applications of AI within RNA vaccines and therapeutic development